CNTB - Company ID 0001835268
The table below shows Connect Biopharma Holdings Ltd's balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $38.34M | $78.23M | - | - | - |
| Short-term investments | $6.00M | $15.48M | - | - | - |
| Receivables | $13.00K | $789.00K | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $50.93M | $96.96M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment |
| $3.81M |
| $4.05M |
| - |
| - |
| - |
| Goodwill | - | - | - | - | - |
| Total assets | $56.08M | $101.28M | $125.89M | $174.01M | $291.05M |
| Accounts payable | $1.96M | $342.00K | - | - | - |
| Total current liabilities | $13.61M | $8.46M | - | - | - |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $14.10M | $9.12M | $24.85M | $16.52M | $18.80M |
| Retained earnings | -$400.83M | -$345.36M | - | - | - |
| Total equity | $41.98M | $92.17M | - | - | - |